Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma.

@article{Bomeisl2015ComparisonOO,
  title={Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma.},
  author={Philip E Bomeisl and Cheryl L. Thompson and Lyndsay N. Harris and Hannah L. Gilmore},
  journal={Archives of pathology & laboratory medicine},
  year={2015},
  volume={139 12},
  pages={
          1546-9
        }
}
CONTEXT Oncotype DX (ODX) is a widely used commercial assay that estimates the risk of distant recurrence and may predict the benefit of chemotherapy in a subset of breast cancers. Some studies have shown the ability to predict Oncotype DX recurrence score (ODXRS), based on routinely reported pathologic features; however, there are limited data correlating specific histologic type of breast cancer to ODXRS. OBJECTIVE To compare ODXRS to specific histologic types of breast cancer. DESIGN One… CONTINUE READING